155 related articles for article (PubMed ID: 36643321)
1. Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer.
Wang L; Zeng X; Yang G; Liu G; Pan Y
Heliyon; 2022 Dec; 8(12):e12553. PubMed ID: 36643321
[TBL] [Abstract][Full Text] [Related]
2. Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
Liu G; Claret FX; Zhou F; Pan Y
Front Pharmacol; 2018; 9():135. PubMed ID: 29535627
[TBL] [Abstract][Full Text] [Related]
3. Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.
Hou J; Liu G; Yuan Y; Wang D; Jiao P; Xing L; Pan Y
Oncotarget; 2017 Nov; 8(57):97504-97515. PubMed ID: 29228627
[TBL] [Abstract][Full Text] [Related]
4. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. Jab1/Cops5: a promising target for cancer diagnosis and therapy.
Yuan C; Wang D; Liu G; Pan Y
Int J Clin Oncol; 2021 Jul; 26(7):1159-1169. PubMed ID: 34019195
[TBL] [Abstract][Full Text] [Related]
7. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
[TBL] [Abstract][Full Text] [Related]
8. The transcription co-factor JAB1/COPS5, serves as a potential oncogenic hub of human chondrosarcoma cells
Mamidi MK; Samsa WE; Danielpour D; Chan R; Zhou G
Am J Cancer Res; 2021; 11(10):5063-5075. PubMed ID: 34765312
[TBL] [Abstract][Full Text] [Related]
9. MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.
Wu B; Pan Y; Liu G; Yang T; Jin Y; Zhou F; Wei Y
Front Oncol; 2019; 9():1170. PubMed ID: 31788446
[TBL] [Abstract][Full Text] [Related]
10. Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51.
Liu G; Yu M; Wu B; Guo S; Huang X; Zhou F; Claret FX; Pan Y
Cell Signal; 2019 Jan; 53():39-48. PubMed ID: 30244171
[TBL] [Abstract][Full Text] [Related]
11. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5.
Wei Y; Liu G; Wu B; Yuan Y; Pan Y
Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract][Full Text] [Related]
13. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
14. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
16.
Ke P; Bao X; Liu C; Zhou B; Huo M; Chen Y; Wang X; Wu D; Ma X; Liu D; Chen S
Transl Cancer Res; 2022 Oct; 11(10):3491-3505. PubMed ID: 36388050
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
18. A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3).
Gong S; Duan Y; Wu C; Osterhoff G; Schopow N; Kallendrusch S
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576068
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive pan-cancer analysis on the immunological role and prognostic value of
Yang Y; Jiang L; Wang S; Chen H; Yi M; Wu Y; Li Z; Fang X
Transl Cancer Res; 2022 Sep; 11(9):3187-3208. PubMed ID: 36237259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
